U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07884864) titled 'A Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) Participants' on Oct. 14.
Brief Summary: This is a clinical study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of AHB-121 injection in healthy and chronic hepatitis B participants.
Study Start Date: Oct. 28
Study Type: INTERVENTIONAL
Condition:
Chronic Hepatitis B Virus
Intervention:
DRUG: AHB-121
AHB-121 will be used per week
DRUG: Placebo
Placebo will be used per week
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Ausper Biopharma Co., Ltd.
Disclaimer: Curated by HT Syndication....